Cite
HARVARD Citation
Pineda Losada, E. et al. (n.d.). 227 Predictive serum biomarkers in metastatic colorectal cancer patients treated in the BECOX trial with oxaliplatin-capecitabine (CAPOX) plus bevacizumab (GEMCAD 09-01). European journal of cancer. pp. S36-. [Online].